Story originally from Bioengineering.
Andrew Smith, associate professor of Bioengineering, is leading a team at Illinois collaborating with the H. Lee Moffitt Cancer Center. The study tags and identifies individual molecules as they pass through a flow cytometer using a novel technique: “single-molecule flow.”
The team is using SM-flow “to detect and quantify one particular biomarker called miR-375, which can be used to predict how patients with prostate cancer will respond to therapy,” Smith said. Find out more about the study, published in ACS Nano.